These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38102650)

  • 1. Managing comorbidities in chronic kidney disease reduces utilization and costs.
    Li Y; Barve K; Cockrell M; Agarwal A; Casebeer A; Dixon SW; Poonawalla I
    BMC Health Serv Res; 2023 Dec; 23(1):1418. PubMed ID: 38102650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annual health care resource utilization and cost among type 2 diabetes patients with newly recognized chronic kidney disease within a large U.S. administrative claims database.
    Folkerts K; Petruski-Ivleva N; Kelly A; Fried L; Blankenburg M; Gay A; Kovesdy CP
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1506-1516. PubMed ID: 33251992
    [No Abstract]   [Full Text] [Related]  

  • 3. Nephrology co-management versus primary care solo management for early chronic kidney disease: a retrospective cross-sectional analysis.
    Samal L; Wright A; Waikar SS; Linder JA
    BMC Nephrol; 2015 Oct; 16():162. PubMed ID: 26458541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of Chronic Kidney Disease Management in Canadian Primary Care.
    Bello AK; Ronksley PE; Tangri N; Kurzawa J; Osman MA; Singer A; Grill AK; Nitsch D; Queenan JA; Wick J; Lindeman C; Soos B; Tuot DS; Shojai S; Brimble KS; Mangin D; Drummond N
    JAMA Netw Open; 2019 Sep; 2(9):e1910704. PubMed ID: 31483474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transition-to-dialysis planning, health care use, and mortality in end-stage renal disease.
    Poonawalla I; Barve K; Cockrell M; Agarwal A; Casebeer AW; Dixon SW; Li Y
    Am J Manag Care; 2023 Feb; 29(2):81-87. PubMed ID: 36811982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Descriptive study of the economic burden among patients with type 2 diabetes mellitus, chronic kidney disease, and chronic kidney disease and type 2 diabetes mellitus in a large US commercially insured population.
    Chung H; Crowe CL; Kong SX; Singh R; Farej R; Elliott J; Williamson T; Willey VJ
    J Manag Care Spec Pharm; 2023 Jan; 29(1):80-89. PubMed ID: 36580126
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population.
    Schwab P; Dhamane AD; Hopson SD; Moretz C; Annavarapu S; Burslem K; Renda A; Kaila S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():735-744. PubMed ID: 28260880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct all-cause health care costs associated with chronic kidney disease in patients with diabetes and hypertension: a managed care perspective.
    Laliberté F; Bookhart BK; Vekeman F; Corral M; Duh MS; Bailey RA; Piech CT; Lefebvre P
    J Manag Care Pharm; 2009 May; 15(4):312-22. PubMed ID: 19422271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrotoxic Medication Exposure in U.S. Adults with Predialysis Chronic Kidney Disease: Health Services Utilization and Cost Outcomes.
    Davis-Ajami ML; Fink JC; Wu J
    J Manag Care Spec Pharm; 2016 Aug; 22(8):959-68. PubMed ID: 27459659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
    Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM
    Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, treatment patterns, and healthcare resource utilization in Medicare and commercially insured non-dialysis-dependent chronic kidney disease patients with and without anemia in the United States.
    St Peter WL; Guo H; Kabadi S; Gilbertson DT; Peng Y; Pendergraft T; Li S
    BMC Nephrol; 2018 Mar; 19(1):67. PubMed ID: 29544446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs and healthcare use of patients with chronic kidney disease in the Northern Territory, Australia.
    Chen W; Howard K; Gorham G; Abeyaratne A; Zhao Y; Adegboye O; Kangaharan N; Talukder MRR; Taylor S; Cass A;
    BMC Health Serv Res; 2024 Jul; 24(1):791. PubMed ID: 38982437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in Chronic Kidney Disease Care in the US by Race and Ethnicity, 2012-2019.
    Chu CD; Powe NR; McCulloch CE; Crews DC; Han Y; Bragg-Gresham JL; Saran R; Koyama A; Burrows NR; Tuot DS;
    JAMA Netw Open; 2021 Sep; 4(9):e2127014. PubMed ID: 34570204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare resource utilization and costs 2 years pre- and post-lumbar spine surgery for stenosis: a national claims cohort study of 22,182 cases.
    Koltsov JCB; Sambare TD; Alamin TF; Wood KB; Cheng I; Hu SS
    Spine J; 2022 Jun; 22(6):965-974. PubMed ID: 35123048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization and costs of medications associated with CKD mineral and bone disorder in dialysis patients enrolled in Medicare Part D.
    Yusuf AA; Howell BL; Powers CA; St Peter WL
    Am J Kidney Dis; 2014 Nov; 64(5):770-80. PubMed ID: 24833203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney involvement in tuberous sclerosis complex: the impact on healthcare resource use and costs.
    Vekeman F; Magestro M; Karner P; Duh MS; Nichols T; van Waalwijk van Doorn-Khosrovani SB; Zonnenberg BA
    J Med Econ; 2015; 18(12):1060-70. PubMed ID: 26201433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic burden of comorbid chronic kidney disease and diabetes.
    McQueen RB; Farahbakhshian S; Bell KF; Nair KV; Saseen JJ
    J Med Econ; 2017 Jun; 20(6):585-591. PubMed ID: 28128669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure management in hypertensive people with non-dialysis chronic kidney disease in Queensland, Australia.
    Zhang J; Healy HG; Venuthurupalli SK; Tan KS; Wang Z; Cameron A; Hoy WE
    BMC Nephrol; 2019 Sep; 20(1):348. PubMed ID: 31484506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Chronic Kidney Disease in Type 2 Diabetes: The Canadian REgistry of Chronic Kidney Disease in Diabetes Outcomes (CREDO) Study.
    Chu L; Fuller M; Jervis K; Ciaccia A; Abitbol A
    Clin Ther; 2021 Sep; 43(9):1558-1573. PubMed ID: 34426012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient characteristics and initiation of mineralocorticoid receptor antagonists in patients with chronic kidney disease in routine clinical practice in the US: a retrospective cohort study.
    Blankenburg M; Fett AK; Eisenring S; Haas G; Gay A
    BMC Nephrol; 2019 May; 20(1):171. PubMed ID: 31096928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.